Key facts
- This page summarizes Kenneth A. Burdick's Form 4 filing for LifeStance Health Group, Inc. (LFST).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Aug 2026, 17:02.
Kenneth A. Burdick - 11 Aug 2026 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)
- Reporting relationship
- Director
- Issuer ticker
- LFST
- Reported as of
- 11 Aug 2026
- Net transaction value
- -$5,755,000
- SEC form
- 4
- Accepted by SEC
- 13 Aug 2026, 17:02:08 UTC
- Prior SEC filing
- 14 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Ryan Pardo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kenneth A. Burdick filed Form 4 for LifeStance Health Group, Inc. (LFST) on 13 Aug 2026.
Change
- Previous filing in this sequence was filed on 14 Jul 2026.
- Current net transaction value: -$5,755,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001498992
Primary reporting owner
Burdick Kenneth A
- Relationship
- Director
- Address
- C/O LIFESTANCE HEALTH GROUP, INC., 4800 N. SCOTTSDALE ROAD, SUITE 2500, SCOTTSDALE
- Signature
- By: /s/ Ryan Pardo, Attorney-in-Fact
- Signature date
- 13 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LFST
transaction
Common Stock
Sale
- Transaction value
- $5,755,000
- Shares
- -500,000
- Change %
- -14%
- Price
- $11.51
- Shares after
- 2,970,810
- Date
- 11 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
LFST
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 46,511
- Date
- 11 Aug 2026
- Ownership
- By Burdick Family LLC
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $11.50 to $11.665 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.